Alpha fetoprotein adenoviral vector vaccine
Term · Oncology and biomedicine · MLC-T-ONC-009972
A vaccine consisting of a recombinant adenoviral vector encoding alpha fetoprotein. After vaccination, expressed alpha fetoprotein may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells that express alpha fetoprotein, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-009972 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | AdVhAFP |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009972",
"term": "Alpha fetoprotein adenoviral vector vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine consisting of a recombinant adenoviral vector encoding alpha fetoprotein. After vaccination, expressed alpha fetoprotein may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells that express alpha fetoprotein, resulting in tumor cell lysis.",
"abbreviation": "AdVhAFP",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/alpha-fetoprotein-adenoviral-vector-vaccine/"
}
Record 870 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.